02Apr 2025
Gantenerumab: New Hope for Early-Onset Alzheimer’s Treatment
Why in the News ? Gantenerumab, a groundbreaking drug, shows promise in treating Early-Onset Alzheimer’s Disease by targeting and reducing amyloid plaques in the brain. It offers potential relief by slowing cognitive decline, pending confirmation from ongoing clinical trials. Gantenerumab: The Promising New Drug Mechanism of Action: Gantenerumab works by targeting and reducing amyloid plaque …
Read More